| ISA | ALKYLATING-DRUG |
| ANCESTORS | ALKYLATING-DRUG ALL ANTINEOPLASTIC-AGENT DRUG MATERIAL OBJECT PHARMACEUTICAL-MATERIAL PHYSICAL-OBJECT THERAPEUTICAL-MATERIAL |
| Oncotepa | term type: synonym reliability code: 10 part of speech: noun number: mass definition: see thiotepa (en) |
| thiotepa | definition: alkylating anticancer drug used in the treatment of superficial papillary carcinoma of urinary bladder, malignant pleural effusions and carcinoma of breast and ovary, sarcoma, glioma and neuroblastoma. Possible side effects are myelosuppression, amenorrhea and azoospermia and potential secondary neoplasms. Intravenous administration. (en) number: mass part of speech: noun reliability code: 10 term type: main entry term |
| TSPA | definition: see thiotepa (en) term type: acronym reliability code: 10 part of speech: noun number: mass |
| Onco-Tiotepa | term type: synonym reliability code: 10 part of speech: noun number: mass gender: feminine definition: véase tiotepa (es) |
| thiotepa | definition: véase tiotepa (es) gender: masculine number: mass part of speech: noun reliability code: 10 term type: synonym |
| tiotepa | gender: masculine definition: fármaco alquilante antineoplásico, utilizado para el tratamiento del cáncer de vejiga superficial, derrame maligno y carcinoma de mama, ovario, sarcoma, glioma y neuroblastoma. Los efectos secundarios más comunes son mielosupresión, neoplasia secundaria potencial, amenorrea y azoospermia. Administración intravenosa. (es) gender: feminine number: mass part of speech: noun reliability code: 10 term type: main entry term |